Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Change in Accured Expenses (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Change in Accured Expenses for 4 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 3000.0% to -$2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.5 million through Dec 2025, down 955.7% year-over-year, with the annual reading at -$2.5 million for FY2025, 955.7% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$2.0 million at Spruce Biosciences, down from $4.9 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $4.9 million in Q3 2025, with the low at -$5.0 million in Q2 2025.
  • Average Change in Accured Expenses over 4 years is $199062.5, with a median of -$48000.0 recorded in 2023.
  • The sharpest move saw Change in Accured Expenses skyrocketed 236.09% in 2023, then tumbled 7275.61% in 2024.
  • Over 4 years, Change in Accured Expenses stood at -$2.8 million in 2022, then surged by 236.09% to $3.9 million in 2023, then tumbled by 101.66% to -$64000.0 in 2024, then crashed by 3000.0% to -$2.0 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$2.0 million, $4.9 million, and -$5.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.